Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Accumulated Expenses (2020 - 2025)

Agilon Health (AGL) has disclosed Other Accumulated Expenses for 6 consecutive years, with $929.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses changed 0.2% year-over-year to $929.8 million, compared with a TTM value of $929.8 million through Dec 2025, changed 0.2%, and an annual FY2025 reading of $929.8 million, changed 0.2% over the prior year.
  • Other Accumulated Expenses was $929.8 million for Q4 2025 at Agilon Health, down from $1.1 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.2 billion in Q3 2024 and bottomed at $44.1 million in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $665.2 million, with a median of $745.6 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses plummeted 34.18% in 2021, then skyrocketed 1929.77% in 2024.
  • Year by year, Other Accumulated Expenses stood at $44.1 million in 2021, then grew by 4.08% to $45.9 million in 2022, then changed by 0.0% to $45.9 million in 2023, then surged by 1929.77% to $931.7 million in 2024, then dropped by 0.2% to $929.8 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for AGL at $929.8 million in Q4 2025, $1.1 billion in Q3 2025, and $1.0 billion in Q2 2025.